Tailor-made Antibodies
and Tools for Life Science
Home|||||Technical Support

VCAM1 antibody mouse specific - HS-470 003

VCAM1 is expressed by cytokine activated endothelium
Rabbit polyclonal purified antibody
Cat. No.: HS-470 003
Amount: 50 µg
Price: $370.00
Cat. No. HS-470 003 50 µg specific antibody, lyophilized. Affinity purified with the immunogen. Albumin and azide were added for stabilization. For reconstitution add 50 µl H2O to get a 1mg/ml solution in PBS. Then aliquot and store at -20°C to -80°C until use.
Antibodies should be stored at +4°C when still lyophilized. Do not freeze!
Applications
 
WB: not tested yet
IP: not tested yet
IHC: 1 : 500 (see remarks) gallery  
IHC-P: 1 : 1000 up to 1 : 2000 gallery  
ELISA: not tested yet
Immunogen Synthetic peptide corresponding to AA 108 to 128 from mouse Vcam1 (UniProt Id: Q3UPN1)
Reactivity Reacts with: mouse (Q3UPN1).
No signal: rat (P29534 ), human (P19320).
Other species not tested yet.
Remarks

IHC: Heat-mediated antigen retrieval (citrate buffer pH 6) is required for immunohistochemical staining

Data sheet hs-470_003.pdf
Important information
This product belongs to the HistoSure product line of antibodies developed for and extensively tested in FFPE tissues.
For more information please visit our HistoSure brand website.
Cat. No.: HS-470 003
Amount: 50 µg
Price: $370.00
Background

Vascular cell adhesion molecule 1 (VCAM1 or CD106) is an endothelial adhesion molecule of the Ig gene superfamily, that regulates leukocyte migration from the blood into tissues (1). Expression of VCAM1 is induced on endothelial cells during inflammatory diseases in response to a number of inflammatory stimuli, including TNFα, lipopolysaccharide or high levels of reactive oxygen species (2). VCAM1 expression in hematopoietic cells is restricted to cells confined to tissues e.g., red pulp macrophages and follicular dendritic cells in the spleen, whereas circulating cells are virtually devoid of VCAM1 (3). VCAM1 has been found to be implicated in various immunological disorders, including rheumatoid arthritis, transplant rejection and cancer and is therefore a potential therapeutic target (4).